Cargando…

Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis

Detalles Bibliográficos
Autores principales: Verstovsek, S, Atallah, E, Mascarenhas, J, Sun, H, Montgomery, M, Gupta, V, Mesa, R, Gotlib, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895165/
https://www.ncbi.nlm.nih.gov/pubmed/26526986
http://dx.doi.org/10.1038/leu.2015.310
_version_ 1782435796993703936
author Verstovsek, S
Atallah, E
Mascarenhas, J
Sun, H
Montgomery, M
Gupta, V
Mesa, R
Gotlib, J
author_facet Verstovsek, S
Atallah, E
Mascarenhas, J
Sun, H
Montgomery, M
Gupta, V
Mesa, R
Gotlib, J
author_sort Verstovsek, S
collection PubMed
description
format Online
Article
Text
id pubmed-4895165
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48951652016-06-21 Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis Verstovsek, S Atallah, E Mascarenhas, J Sun, H Montgomery, M Gupta, V Mesa, R Gotlib, J Leukemia Letter to the Editor Nature Publishing Group 2016-06 2015-11-27 /pmc/articles/PMC4895165/ /pubmed/26526986 http://dx.doi.org/10.1038/leu.2015.310 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Letter to the Editor
Verstovsek, S
Atallah, E
Mascarenhas, J
Sun, H
Montgomery, M
Gupta, V
Mesa, R
Gotlib, J
Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
title Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
title_full Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
title_fullStr Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
title_full_unstemmed Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
title_short Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
title_sort efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895165/
https://www.ncbi.nlm.nih.gov/pubmed/26526986
http://dx.doi.org/10.1038/leu.2015.310
work_keys_str_mv AT verstovseks efficacyofruxolitinibonhepatomegalyinpatientswithmyelofibrosis
AT atallahe efficacyofruxolitinibonhepatomegalyinpatientswithmyelofibrosis
AT mascarenhasj efficacyofruxolitinibonhepatomegalyinpatientswithmyelofibrosis
AT sunh efficacyofruxolitinibonhepatomegalyinpatientswithmyelofibrosis
AT montgomerym efficacyofruxolitinibonhepatomegalyinpatientswithmyelofibrosis
AT guptav efficacyofruxolitinibonhepatomegalyinpatientswithmyelofibrosis
AT mesar efficacyofruxolitinibonhepatomegalyinpatientswithmyelofibrosis
AT gotlibj efficacyofruxolitinibonhepatomegalyinpatientswithmyelofibrosis